News
MHRA okays first drug under new mutual recognition scheme
A new formulation of Amgen’s cancer treatment Xgeva is the first to …
19738 items found
News
Pfizer’s new cancer unit sees eight new blockbusters by 2030
Fresh from the $43 billion acquisition of antibody-drug conjugate …
R&D
Planning strategies for transitioning to the Clinical Trials Regulation
There is a pressing need for companies to transition their EU …
News
New film aims to raise awareness of rare disease cALD
Rare Disease Day saw the debut of a film that aims to raise awareness …
News
Ironwood felled by mixed data in short bowel syndrome trial
Ironwood Pharma has issued an upbeat assessment of phase 3 trial data …
News
In U-turn, NICE backs first drug for AL amyloidosis
Almost four years after it was approved in Europe to treat the …
Market Access
The 2024 biopharma M&A landscape: An overview
It’s been a couple of months since pharma’s annual JP Morgan Chase …
News
Sandoz will pay $265m to settle price fixing case in US
Generic and biosimilar drug producer Sandoz has agreed a $265 million …
Market Access
Seizing the moment: The life sciences industry at the threshold of change
The passage of the Inflation Reduction Act (IRA) signifies more than …
Market Access
Sponsored
Scaling innovation across hospitals and nations
Creating healthcare interventions and technological solutions that …
News
Palatin pummelled as dry eye therapy underwhelms in phase 3
Palatin Technologies’ therapy for dry eye disease (DED) missed its …
Sales & Marketing
Sponsored
News
MSD, Moderna start phase 3 adjuvant lung cancer trial
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-sta
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
